RecruitingNCT06519162
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Exploration of Liver-gut Axis Through Identification of Liver Disease-specific Microbiome
Sponsor
Chungnam National University Hospital
Enrollment
3,000 participants
Start Date
Jul 8, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.
Eligibility
Min Age: 19 Years
Inclusion Criteria3
- Adults aged 19 years and older diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, who have consented to participate in this study at Chungnam National University Hospital.
- Adults aged 19 years and older, who are cohabitants of patients diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, and have consented to participate in this study at Chungnam National University Hospital.
- B. Exclusion
Exclusion Criteria2
- Individuals under the age of 19.
- Patients or guardians who do not consent to participate in the study
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06519162
Related Trials
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
NCT046852001 location
Additive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver Issues
NCT075992411 location
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
NCT038840751 location
Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients
NCT062503091 location
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
NCT073875491 location